Dade Behring

Last updated

Dade Behring was a company which manufactured testing machinery and supplies for the medical diagnostics industry, based in Deerfield, Illinois and Glasgow, Delaware (formerly a DuPont site).

Contents

History

Behring Diagnostics, a Frankfurt-based [1] company bearing Dr. Emil von Behring's name, was spun off from Hoechst AG (which later became Aventis) in 1995. Soon after its formation, the company acquired a drug-testing firm called Syva Company and, in 1996, the diagnostics and clinical chemistry division of DuPont. [2]

Dade Behring was born from the merger of Behring Diagnostics and Deerfield, Illinois-based [1] Dade International, a private, independent company created by a group of investors led by Bain Capital [3] who had bought Baxter International's diagnostics unit for over $440 million, in late 1994. The combined operations of the two companies reached sales of $1.2 billion and employed a workforce of 6,400 worldwide.

The new firm became the world's largest company devoted to diagnostics, with sales of over $500 million. The "Dade" part of the name is a legacy of the Dade Reagents Company, founded by Dr. John Elliott near the end of the 1940s to provide consistent, high quality typing and testing of blood.

Jim Reid-Anderson joined Dade Behring Holdings Inc, in 1996 as executive vice president and chief financial officer (CFO) and became chief administrative officer and CFO in September 1997.

Nelson Chai joined Dade Behring in 1997 as corporate vice president of worldwide field finance; he later became their senior vice president of business development. [4]

In April 1999, Reid-Anderson was promoted to the role of president and chief operating officer and then CEO in September 2000. He was elected as the chairman of the board in October 2002.

In 2002 the company filed for Chapter 11 bankruptcy, but then reorganized and recovered in a spectacular way. Brad Pattelli was on the board of directors and an influential figure in the reorganization. By 2005, the firm employed more than 6,000 workers and had operations in 43 countries to serve more than 25,000 medical customers.

With 2006 revenue of more than $1.7 billion, Dade Behring was the world's largest company solely dedicated to clinical diagnostics, as opposed to competitors like Abbott and Roche, whose operations covered other markets including the pharmaceutical industry.

In 2007 Dade Behring was acquired by the German conglomerate Siemens AG. [5] Based on Dade's 83 million outstanding shares, Siemens’ offer of $77 a share in cash, on a diluted basis, had a value of nearly $6.4 billion.

Products

People associated with Dade Behring

See also

Related Research Articles

<span class="mw-page-title-main">Siemens</span> German multinational conglomerate company

Siemens is a German multinational conglomerate corporation and the largest industrial manufacturing company in Europe. It is headquartered in Munich and has several foreign branch offices.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013. The CEO of Abbott said in 2015 that the company had been in India for over a century; it was named Abbott India Ltd. in 2002.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.

<span class="mw-page-title-main">Chiron Corporation</span> American biotechnology firm (1981-2006)

Chiron Corporation was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Bain Capital is an American private investment firm based in Boston. It specializes in private equity, venture capital, credit, public equity, impact investing, life sciences, and real estate. Bain Capital invests across a range of industry sectors and geographic regions. As of 2022, the firm managed approximately $160 billion of investor capital. The firm was founded in 1984 by partners from the consulting firm Bain & Company. The company is headquartered at 200 Clarendon Street in Boston with 22 offices in North America, Europe, Asia, and Australia.

<span class="mw-page-title-main">John Thain</span> American businessman

John Alexander Thain is an American financial executive and investment banker. He served as President and co-COO of Goldman Sachs, and then CEO of the New York Stock Exchange. Thain then became the last chairman and CEO of Merrill Lynch before its merger with Bank of America. He was designated to become president of global banking, securities, and wealth management at the newly combined company, but resigned on January 22, 2009. Ken Lewis, CEO of Bank of America, reportedly forced Thain to step down after several controversies, such as the losses at Merrill Lynch which proved to be far larger than previously estimated, and the award of huge executive bonuses. Thain then served as chairman and CEO of the CIT Group. He is currently a board member of Uber appointed by former Uber chief executive officer Travis Kalanick on September 29, 2017.

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Siemens Healthineers is a German medical device company. It is the parent company for several medical technology companies and is headquartered in Erlangen, Germany. The company dates its early beginnings in 1847 to a small family business in Berlin, co-founded by Werner von Siemens. Siemens Healthineers is 75% owned by Siemens. The name Siemens Medical Solutions was adopted in 2001, and the change to Siemens Healthcare was made in 2008. In 2015, Siemens named Bernd Montag as its new global CEO. In May 2016, the business operations of Siemens Healthcare were rebranded "Siemens Healthineers."

Ortho Clinical Diagnostics is an in vitro diagnostics company that makes products and diagnostic equipment for blood testing. Ortho serves two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion recipients receive appropriate and compatible blood.
Johnson and Johnson acquired Eastman Kodak's Clinical Diagnostics Division in 1994, which was then merged with Ortho Diagnostic Systems in 1997. Ortho's global corporate offices are in Raritan, New Jersey, while their global research and development center is in Rochester, New York.

<span class="mw-page-title-main">Medical laboratory</span> Principles of management with special reference to medical science

A medical laboratory or clinical laboratory is a laboratory where tests are conducted out on clinical specimens to obtain information about the health of a patient to aid in diagnosis, treatment, and prevention of disease. Clinical Medical laboratories are an example of applied science, as opposed to research laboratories that focus on basic science, such as found in some academic institutions.

Nelson Joosuk Chai is an American investment banker and financial executive. He formerly served as the chief financial officer of American financial services company Merrill Lynch and briefly as Bank of America's president for the Asia-Pacific region. He is the former president of CIT Group and reported directly to then CEO John Thain. On August 21, 2018, it was announced that Chai has been hired as the chief financial officer of Uber.

Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996.

James Reid-Anderson is a British businessman who was formerly the president, chairman, and chief executive officer (CEO) of Six Flags Entertainment Corporation. Before working for Six Flags, Anderson was previously a healthcare adviser to both Apollo and the managing board of Siemens AG. Under Reid-Anderson, Dade Behring was acquired by Siemens.

Merrill, previously branded Merrill Lynch, is an American investment management and wealth management division of Bank of America. Along with BofA Securities, the investment banking arm, both firms engage in prime brokerage and broker-dealer activities. The firm is headquartered in New York City, and once occupied the entire 34 stories of 250 Vesey Street, part of the Brookfield Place complex in Manhattan. Merrill employs over 14,000 financial analysts and manages $2.3 trillion in client assets. The company also operates Merrill Edge, a division for investment and related services, including call center counsultancy.

Behring may refer to:

<span class="mw-page-title-main">DiaSorin</span> Italian biotechnoloty company

DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and since July 2021, it is also active in the Life Science business. The group was founded in 2000 and is headquartered in Saluggia, Italy. Its production is at several plants located in Europe and the United States: Saluggia and Gerenzano (Italy), Dietzenbach (Germany), Stillwater, Minnesota (US), Dartford (UK). Following the acquisition of Luminex, the company acquired five additional production plants located in the USA and in Canada (Toronto). The company is a constituent of the FTSE MIB index.

<span class="mw-page-title-main">Laurence Tosi</span> American entrepreneur, investor, and philanthropist

Laurence A. Tosi is an American entrepreneur, investor, and philanthropist. Tosi is currently Managing Partner of WestCap Group, the investment firm he founded. In October 2020, it was reported that Tosi's firm was in the final stages of raising a $750 million fund and had received about $1.2 billion of investor interest to date. Prior to dedicating his time to WestCap, Tosi served as the chief financial officer of Airbnb and of The Blackstone Group and held several roles at BofA Merrill Lynch.

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.

Thomas C. Naratil is an American business executive in the financial industry. After serving as president of both UBS Wealth Management Americas and UBS Americas since early 2016, Naratil was appointed CEO of UBS Americas Holding LLC and became co-president of Global Wealth Management of UBS Group AG and UBS AG in early 2018. Naratil started his career in finance in 1983 when he joined the brokerage firm Paine Webber Jackson & Curtis. The Swiss bank UBS acquired PaineWebber in 2000 and Naratil would hold various senior management positions at UBS Group, including chief financial officer (CFO) and chief operating officer (COO) from 2014 to 2015. Naratil succeeded Robert McCann as president of both UBS Wealth Management Americas and UBS Americas. In 2016, Naratil led a reorganization that involved cutting recruitment of US advisors and thinning management ranks, while also increasing compensation for UBS advisors. He is on the boards of organizations such as the American Swiss Foundation and College of Nursing at Villanova University, and has served on its Clearing House Supervisory Board.

Joseph Willit is an American investment banker who served as the chief financial officer (CFO) of investment bank Merrill Lynch & Co. from 1993 to 1998. He would go on to serve as the chief operating officer (COO) Merrill Lynch's European operations from 1998 to 2002, succeeded by Andrea Orcel.

References

  1. 1 2 Hutchcraft, Chuck (March 13, 1997). "Dade Sets Merger With Unit Of Hoechst". Chicago Tribune . Retrieved November 17, 2016.
  2. fundinguniverse.com Dade Behring history
  3. Michael Barbaro (November 13, 2011). "After a Romney Deal, Profits and Then Layoffs". The New York Times . Retrieved November 13, 2011.
  4. "Merrill Lynch Names Nelson Chai as Chief Financial Officer", Press release, Merrill Lynch, 2007-12-03, archived from the original on 2008-09-23, retrieved 2007-12-12
  5. Siemens Sells One Business and Buys Another, New York Times
  6. FDA Pre-market Notification, FDA.report